GABAergic Signaling in Neuroscience Research: GABA-A, GABA-B and Selank

Gamma-aminobutyric acid, commonly known as GABA, is the principal inhibitory neurotransmitter in the mature mammalian central nervous system.

GABAergic signaling helps regulate neuronal excitability and contributes to the balance between excitatory and inhibitory activity across neural networks.

Rather than functioning through a single receptor, GABA produces its effects through distinct receptor systems—most importantly GABA-A and GABA-B receptors.

Understanding these systems provides an important foundation for neuroscience research involving inhibitory neurotransmission, receptor modulation, neural-network activity, and compounds such as Selank.

What Is GABA?

GABA stands for gamma-aminobutyric acid.

It is synthesized in the nervous system primarily from glutamate through an enzymatic reaction involving glutamic acid decarboxylase.

After synthesis, GABA can be packaged into synaptic vesicles and released from GABAergic neurons.

Once released, GABA interacts with receptors on neighboring cells and helps regulate neuronal activity.

In the mature central nervous system, this signaling generally reduces neuronal excitability.

What Is Inhibitory Neurotransmission?

Neurons constantly receive combinations of excitatory and inhibitory signals.

Excitatory signaling tends to increase the probability that a neuron will generate an action potential, whereas inhibitory signaling can decrease that probability or regulate the timing and magnitude of neuronal activity.

GABAergic neurotransmission provides a major source of this inhibitory control.

This does not mean that inhibition simply “turns neurons off.”

Inhibitory signaling helps organize when neurons fire, how neural networks synchronize, and how information moves through neural circuits.

Excitation and Inhibition Balance

Brain function depends on coordinated interactions between excitation and inhibition, sometimes referred to as E/I balance.

Glutamate provides much of the major excitatory neurotransmission in the central nervous system, while GABA provides much of its inhibitory neurotransmission.

These systems interact continuously.

Appropriate network activity depends not on maximizing either excitation or inhibition, but on dynamically regulating both.

GABAergic interneurons can therefore influence:

• Neural-network timing

• Sensory processing

• Cortical activity

• Oscillatory rhythms

• Synaptic plasticity

• Information processing

• Neuronal excitability

The exact role of GABAergic signaling varies substantially among neural circuits.

The Two Major GABA Receptor Systems

GABA signaling occurs primarily through two major receptor families:

GABA-A receptors

and

GABA-B receptors

Although both respond to GABA, their structures and signaling mechanisms are fundamentally different.

GABA-A receptors are ionotropic receptors, meaning that the receptor itself contains an ion channel.

GABA-B receptors are metabotropic G protein-coupled receptors, meaning they influence intracellular signaling pathways and ion channels through G proteins.

This distinction produces very different signaling timescales.

What Is the GABA-A Receptor?

The GABA-A receptor (GABA-AR) is a pentameric ligand-gated ion channel assembled from five receptor subunits.

When GABA binds to appropriate sites on the receptor, the channel can open and alter chloride-ion movement across the neuronal membrane.

In mature neurons under typical physiological conditions, this generally contributes to inhibitory signaling.

GABA-A receptors mediate much of the fast inhibitory neurotransmission in the mammalian brain.

GABA-A Receptor Structure

GABA-A receptors are not a single uniform receptor.

Multiple subunit families can combine to produce different receptor subtypes.

Common subunit families include:

• Alpha

• Beta

• Gamma

• Delta

• Other less common subunits

Different subunit combinations can alter receptor location, pharmacology, kinetics, and sensitivity to modulators.

This receptor diversity is one reason compounds that influence GABA-A signaling can produce different biological effects.

Phasic and Tonic Inhibition

GABA-A receptors participate in at least two important forms of inhibitory signaling.

Phasic inhibition generally involves receptors located at synapses responding rapidly to GABA released into the synaptic cleft.

Tonic inhibition can involve extrasynaptic GABA-A receptors responding to lower concentrations of GABA present outside the immediate synapse.

Together, these systems allow GABA to regulate both rapid synaptic events and broader background levels of neuronal excitability.

What Is the GABA-B Receptor?

The GABA-B receptor (GABA-BR) is fundamentally different from GABA-A.

Rather than being an ion channel, GABA-B is a G protein-coupled receptor.

Functional GABA-B receptors are formed from GABA-B1 and GABA-B2 subunits.

Activation produces slower and more prolonged inhibitory signaling than GABA-A receptor activation.

How GABA-B Signaling Works

GABA-B receptors primarily signal through Gi/o-family G proteins.

Their activation can influence several downstream mechanisms.

Presynaptically, GABA-B signaling can inhibit voltage-gated calcium channels and reduce neurotransmitter release.

Postsynaptically, signaling can activate G protein-gated inwardly rectifying potassium channels, commonly called GIRK channels.

GABA-B activation can also inhibit adenylyl cyclase and influence intracellular cAMP signaling.

A simplified pathway is:

GABA → GABA-B receptor → Gi/o signaling → Ion-channel and second-messenger regulation → Reduced neuronal excitability

This produces slower inhibitory effects compared with the rapid ion-channel activity of GABA-A receptors.

GABA-A vs. GABA-B

The two systems can be summarized conceptually as:

GABA-A
→ Ligand-gated ion channel
→ Chloride conductance
→ Fast inhibition

GABA-B
→ G protein-coupled receptor
→ Gi/o signaling
→ Potassium and calcium channel regulation
→ Slower, prolonged inhibition

Both systems contribute to inhibitory neurotransmission, but they accomplish this through different molecular mechanisms.

What Is Receptor Modulation?

A compound does not necessarily need to occupy the primary neurotransmitter-binding site to influence a receptor.

Some molecules interact with allosteric sites located elsewhere on a receptor.

An allosteric modulator can alter how the receptor responds to its primary ligand.

This concept is particularly important in GABA receptor pharmacology.

The biological effect of receptor modulation depends on the receptor subtype, binding location, concentration, endogenous neurotransmitter activity, and other factors.

Benzodiazepines and GABA-A Receptors

Benzodiazepines provide a well-known example of GABA-A receptor modulation.

They bind to particular GABA-A receptor subtypes at an allosteric site distinct from the primary GABA-binding site.

Their presence can enhance certain receptor responses to endogenous GABA.

This is different from simply acting as GABA itself.

The distinction between direct receptor agonism and allosteric modulation is important when discussing compounds that influence GABAergic signaling.

Selank and GABAergic Research

Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin.

It has been investigated primarily in Russian and Eastern European research involving neurobiology and behavioral responses.

Experimental studies have examined relationships between Selank and GABAergic signaling.

Research using radioligand-receptor methods has reported that Selank can influence GABA binding and has proposed concentration-dependent allosteric modulation of GABA receptors as one possible mechanism associated with its experimental effects.

Selank Is Not Simply a Benzodiazepine-Like Compound

It is important not to describe Selank as simply producing the same receptor interaction as a benzodiazepine.

Experimental research comparing Selank with compounds including diazepam has reported different patterns of receptor modulation.

The proposed Selank interaction does not appear to be identical to the classical benzodiazepine binding mechanism.

A more scientifically appropriate description is therefore:

Selank has been investigated for its potential modulation of GABAergic signaling.

The precise molecular mechanisms, receptor-subtype relationships, and relevance of these findings to humans require further investigation.

Selank and Gene-Expression Research

Selank research has also extended beyond direct receptor-binding experiments.

Experimental studies have investigated changes in gene expression associated with neurotransmitter systems and cellular signaling following Selank exposure.

This is important because neural signaling involves more than the immediate interaction between a ligand and receptor.

Longer-term cellular responses can involve:

• Receptor regulation

• Gene transcription

• Protein synthesis

• Intracellular signaling

• Neurotransmitter metabolism

• Network adaptation

These mechanisms may interact, making it difficult to reduce a peptide's biological activity to one receptor pathway.

GABAergic Signaling and Neural Networks

GABAergic neurons play important roles in regulating neural-network activity.

Inhibitory interneurons can control the timing and synchronization of excitatory neurons.

This contributes to oscillatory activity across brain regions.

GABAergic signaling therefore participates in network-level processes involved in sensory processing, cognition, memory, and other forms of neural information processing.

The effects depend heavily on the specific circuit and neuronal populations involved.

GABA and Neuroplasticity

Although GABA is generally associated with inhibition, GABAergic signaling also participates in neuroplasticity.

Changes in inhibitory signaling can alter the conditions under which neural circuits strengthen, weaken, or reorganize connections.

GABA-B receptors, for example, can influence neurotransmitter release and intracellular signaling associated with synaptic plasticity.

Neuroplasticity therefore reflects interactions between excitatory signaling, inhibitory signaling, neurotrophic factors, gene expression, and cellular metabolism.

Developmental Differences in GABA Signaling

GABA should not universally be described as inhibitory under every biological condition.

During early neural development, intracellular chloride concentrations differ from those typically found in mature neurons.

As a result, activation of GABA-A receptors can produce depolarizing responses during certain developmental stages.

Changes in chloride transporters during maturation contribute to the transition toward the predominantly inhibitory GABA-A signaling associated with the mature nervous system.

This is another example of why biological signaling must be interpreted within its cellular context.

Why GABAergic Research Matters

GABAergic signaling intersects with numerous areas of neuroscience, including:

• Neural excitability

• Synaptic transmission

• Network synchronization

• Neuroplasticity

• Sensory processing

• Motor control

• Sleep-related circuitry

• Cognitive processing

Studying GABA-A and GABA-B receptors allows researchers to investigate how different forms of inhibition regulate nervous-system function.

Interpreting Selank Research

Evidence surrounding Selank should be interpreted according to the experimental model used.

The literature includes molecular, cellular, animal, and limited human research, much of it originating outside the large clinical-development programs typically associated with approved pharmaceuticals.

Mechanistic findings involving receptor binding or gene expression do not automatically establish specific therapeutic outcomes in humans.

Researchers should therefore distinguish among:

• Receptor-binding experiments

• Cell-culture studies

• Animal models

• Human studies

• Established clinical evidence

This distinction is particularly important when evaluating claims surrounding experimental research peptides.

Continue Exploring Neuroscience Research

For additional background on receptor biology, read How Peptide Signaling and Receptors Work.

For related neurobiology, explore BDNF, NGF and Neuroplasticity: A Scientific Overview in the Chimera Research Labs Research Library.

You can also explore our Neuroscience Research collection and the Selank research compound page for additional compound-specific information.

Research Use Only

Research compounds offered by Chimera Research Labs are intended for laboratory research purposes only.

They are not intended for human consumption or self-administration and are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Research compounds should be handled only in accordance with applicable laws, regulations, institutional requirements, and appropriate laboratory practices.